NCT00034957

Brief Summary

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2002

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2002

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2002

Completed
Last Updated

February 16, 2012

Status Verified

February 1, 2012

First QC Date

May 2, 2002

Last Update Submit

February 14, 2012

Conditions

Keywords

Pharmacia

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Research Center

Berkeley, California, 94704, United States

Location

Research Center

Greenbrae, California, 94904-2007, United States

Location

Research Center

Los Angeles, California, 90048, United States

Location

Research Center

Rancho Mirage, California, 92270, United States

Location

Research Center

Chicago, Illinois, 60637-1463, United States

Location

Research Center

Louisville, Kentucky, 40202, United States

Location

Research Center

West Boylston, Massachusetts, 01583, United States

Location

Research Center

Ann Arbor, Michigan, 48109, United States

Location

Research Center

Lebanon, New Hampshire, 03756, United States

Location

Research Center

Nashville, Tennessee, 37232-6868, United States

Location

Research Center

Arlington, Texas, 76012, United States

Location

Research Center

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell LungLung Neoplasms

Interventions

Drugs, Investigational

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Pharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2002

First Posted

May 3, 2002

Primary Completion

October 1, 2002

Study Completion

October 1, 2002

Last Updated

February 16, 2012

Record last verified: 2012-02

Locations